The world’s first! Astellas Claudin18.2 monoclonal antibody approved in Japan
On March 26, Astellas announced that its Claudin18.2 antibody Zolbetuximab (Vyloy) was approved for marketing in Japan, and the approved...
On March 26, Astellas announced that its Claudin18.2 antibody Zolbetuximab (Vyloy) was approved for marketing in Japan, and the approved...
What is the difference between benign and malignant brain tumors? Brain tumors are indeed divided into benign and malignant, but...
Multiple nodules in both lungs may be caused by lung cancer, pneumonia, tuberculosis, etc., and require targeted treatment based on...
JACUS Pharmaceuticals (1167.HK) announced that its independently developed P53 Y220C activator JAB-30300 has been approved for new drug clinical trial...
Placed discreetly within the male reproductive system, the prostate gland serves as a crucial but often overlooked component of men’s...
Whether you have lung cancer can be determined through imaging examinations, tumor marker examinations, pathological examinations, etc. If you get...
Recently, "The Lancet-Oncology" published the results of a randomized controlled umbrella phase II clinical study from China called "FUTURE-SUPER" for...
The survival period of thyroid cancer patients mainly depends on the patient's condition, treatment and physical fitness. If the patient...
The term ‘brain tumour’ can sound frightening, but not all of them are fatal. Some may not even require treatment....
From the perspective of Chinese people, there are two major choices for medical treatment. One is that most people look...
After metastasis occurs in the advanced stage of lung cancer, patients can undergo comprehensive treatment through radiotherapy, chemotherapy, targeted therapy,...
Cancer is a general term for a large group of diseases, the common denominator of which is uncontrolled cell proliferation....